Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Carson

Showing results (781-790 of 918) with videos related to

Pageof 92
Sort By:
JACC. Heart Failure|April 15, 2019
Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection FractionLi Shen, Pardeep S Jhund, Kieran F Docherty, et al.
Addiction Biology|December 1, 2021
Lower prefrontal cortical synaptic vesicle binding in cocaine use disorder: An exploratory <sup>11</sup> C-UCB-J positron emission tomography study in humansGustavo A Angarita, Patrick D Worhunsky, Mika Naganawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2017
Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid TumorsHoward A Burris, Jeffrey R Infante, Stephen M Ansell, et al.
Circulation|November 20, 2014
International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fractionSøren L Kristensen, Lars Køber, Pardeep S Jhund, et al.
European Journal of Heart Failure|December 11, 2012
Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillationDavid P Kao, Gordon Davis, Ryan Aleong, et al.
Molecular Cancer Research : MCR|November 28, 2023
Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine KinaseHimanshu Savardekar, Carter Allen, Hyeongseon Jeon, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 6, 2023
Assessment of Gray Matter Microstructure and Synaptic Density in Alzheimer's Disease: A Multimodal Imaging Study With DTI and SV2A PETJason A Silva-Rudberg, Elaheh Salardini, Ryan S O'Dell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 19, 2024
Validation of a Simplified Tissue-to-Reference Ratio Measurement Using SUVR to Assess Synaptic Density Alterations in Alzheimer Disease with [<sup>11</sup>C]UCB-J PETJuan J Young, Ryan S O'Dell, Mika Naganawa, et al.
Circulation|March 17, 2010
Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trialMichael R Zile, William H Gaasch, Inder S Anand, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Optimized reference region and the effect on test-retest reliability and detection of Parkinson's disease with [<sup>11</sup>C]UCB-JNikkita Khattar, David Matuskey, Jean-Dominique Gallezot, et al.
Pageof 92

Showing results (781-790 of 918) with videos related to

Sort By:
Pageof 92
JACC. Heart Failure|April 15, 2019
Prior Pacemaker Implantation and Clinical Outcomes in Patients With Heart Failure and Preserved Ejection FractionLi Shen, Pardeep S Jhund, Kieran F Docherty, et al.
Addiction Biology|December 1, 2021
Lower prefrontal cortical synaptic vesicle binding in cocaine use disorder: An exploratory <sup>11</sup> C-UCB-J positron emission tomography study in humansGustavo A Angarita, Patrick D Worhunsky, Mika Naganawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2017
Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid TumorsHoward A Burris, Jeffrey R Infante, Stephen M Ansell, et al.
Circulation|November 20, 2014
International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fractionSøren L Kristensen, Lars Køber, Pardeep S Jhund, et al.
European Journal of Heart Failure|December 11, 2012
Effect of bucindolol on heart failure outcomes and heart rate response in patients with reduced ejection fraction heart failure and atrial fibrillationDavid P Kao, Gordon Davis, Ryan Aleong, et al.
Molecular Cancer Research : MCR|November 28, 2023
Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine KinaseHimanshu Savardekar, Carter Allen, Hyeongseon Jeon, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|September 6, 2023
Assessment of Gray Matter Microstructure and Synaptic Density in Alzheimer's Disease: A Multimodal Imaging Study With DTI and SV2A PETJason A Silva-Rudberg, Elaheh Salardini, Ryan S O'Dell, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 19, 2024
Validation of a Simplified Tissue-to-Reference Ratio Measurement Using SUVR to Assess Synaptic Density Alterations in Alzheimer Disease with [<sup>11</sup>C]UCB-J PETJuan J Young, Ryan S O'Dell, Mika Naganawa, et al.
Circulation|March 17, 2010
Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trialMichael R Zile, William H Gaasch, Inder S Anand, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Optimized reference region and the effect on test-retest reliability and detection of Parkinson's disease with [<sup>11</sup>C]UCB-JNikkita Khattar, David Matuskey, Jean-Dominique Gallezot, et al.
Pageof 92